Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinases (MAPKs) are a family of serine/threonine-specific protein kinases that play a central role in transducing extracellular signals into various intracellular responses. They are key regulators of essential cellular processes, including proliferation, gene expression, differentiation, mitosis, cell survival, and apoptosis. MAPKs are activated by a wide range of stimuli and function within highly conserved signaling modules known as MAPK cascades or pathways. These kinases are regulated by phosphorylation and dephosphorylation events. Major subfamilies include ERKs, JNKs, and p38 isoforms. MAPKs are evolutionarily conserved and regulate diverse cellular programs.
Inhibition of kinase activity; Modulation of phosphorylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase (MAPK).